Suppr超能文献

肯尼亚巴林戈县的人类布鲁氏菌病:评估使用的诊断试剂盒并确定感染的布鲁氏菌种。

Human brucellosis in Baringo County, Kenya: Evaluating the diagnostic kits used and identifying infecting Brucella species.

机构信息

Department of Biochemistry, University of Nairobi, Nairobi, Kenya.

Department of Veterinary Pathology, Microbiology and Parasitology, University of Nairobi, Nairobi, Kenya.

出版信息

PLoS One. 2023 Jan 31;18(1):e0269831. doi: 10.1371/journal.pone.0269831. eCollection 2023.

Abstract

Human brucellosis diagnosis has been a challenge in Brucella-endemic areas. In Kenya, diagnosis is usually carried out using Febrile Brucella Antigen agglutination test (FBAT) whose performance is not well documented. This paper reports on the sensitivity and specificity of the FBAT used for brucellosis diagnosis on blood samples/serum collected in three healthcare facilities in Baringo County, Kenya, and on Brucella species present in the study area. The FBAT test results at the hospitals were used to guide patient management. Patients who visited the hospital's laboratory with a clinician's request for brucellosis testing also filled a questionnaire to assess knowledge and attitudes associated with transmission of the disease in the study area. The remaining serum samples were tested again using FBAT and Rose Bengal Plate Test (RBPT) within a month of blood collection at the University Nairobi Laboratory. The two rapid tests were then compared, with respect to brucellosis diagnostic sensitivity and specificity. To identify infecting Brucella species, a proportion 43% (71/166) of the blood clots were analyzed by multiplex polymerase chain reaction (PCR) using specific primers for B. abortus, B. melitensis, B. ovis and B. suis. Out of 166 serum samples tested, 26.5% (44/166) were positive using FBAT and 10.2% (17/166) positive using RBPT. The sensitivity and specificity of FBAT compared to RBPT was 76.47% and 71.19%, respectively while the positive and negative predictive values were 29.55% and 96.72%, respectively. The FBAT showed higher positivity then RBPT. The difference in sensitivity and specificity of FBAT and RBPTs was relatively low. The high FBAT positivity rate would be indication of misdiagnosis; this would lead to incorrect treatment. Brucella abortus was detected from 9.9% (7/71) of the blood clots tested; no other Brucella species were detected. Thus human brucellosis, in Baringo was mainly caused by B. abortus.

摘要

人类布鲁氏菌病的诊断在布鲁氏菌病流行地区一直是一个挑战。在肯尼亚,通常使用发热布鲁氏菌抗原凝集试验(FBAT)进行诊断,但该试验的性能并未得到很好的记录。本文报告了在肯尼亚巴林戈县的三个医疗机构采集的血液样本/血清中使用 FBAT 进行布鲁氏菌病诊断的灵敏度和特异性,以及研究区域中存在的布鲁氏菌种。医院的 FBAT 检测结果用于指导患者管理。那些因临床医生要求进行布鲁氏菌病检测而到医院实验室就诊的患者还填写了一份问卷,以评估该疾病在研究区域传播的相关知识和态度。在收集血液后一个月内,在肯尼亚内罗毕大学实验室,使用 FBAT 和虎红平板试验(RBPT)再次检测其余的血清样本。然后比较了这两种快速检测方法,以确定布鲁氏菌病诊断的灵敏度和特异性。为了鉴定感染的布鲁氏菌种,使用针对 B.abortus、B.melitensis、B.ovis 和 B.suis 的特定引物,对 43%(71/166)的血凝块进行了多重聚合酶链反应(PCR)分析。在检测的 166 份血清样本中,44%(44/166)使用 FBAT 呈阳性,10.2%(17/166)使用 RBPT 呈阳性。与 RBPT 相比,FBAT 的灵敏度和特异性分别为 76.47%和 71.19%,阳性预测值和阴性预测值分别为 29.55%和 96.72%。FBAT 的阳性率高于 RBPT。FBAT 和 RBPT 的灵敏度和特异性差异相对较低。FBAT 阳性率高可能表明误诊,这将导致治疗不当。从检测的 71 个血凝块中检测到 9.9%(7/71)的 B.abortus;未检测到其他布鲁氏菌种。因此,巴林戈的人类布鲁氏菌病主要由 B.abortus 引起。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaf/9888686/fa9cab0e561c/pone.0269831.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验